Effects of the new benzimidazole derivative TAS-203, an orally active phosphodiesterase 4 inhibitor, on airway inflammation in rats and emetic responses in ferrets.
第一作者:
Naomasa,Asaka
第一单位:
Advanced Research Laboratory, Taiho Pharmaceutical Co. Ltd., Saitama, Japan. nasaka@taiho.co.jp
作者:
主题词
动物(Animals);消炎药(Anti-Inflammatory Agents);苯咪唑类(Benzimidazoles);趋化性, 白细胞(Chemotaxis, Leukocyte);克隆, 分子(Cloning, Molecular);环核苷酸磷酸二酯酶类, 4型(Cyclic Nucleotide Phosphodiesterases, Type 4);环己酸类(Cyclohexanecarboxylic Acids);雪貂(Ferrets);豚鼠(Guinea Pigs);人类(Humans);炎症(Inflammation);脂多糖类(Lipopolysaccharides);男(雄)性(Male);腈类(Nitriles);磷酸二酯酶4抑制剂(Phosphodiesterase 4 Inhibitors);血小板活化因子(Platelet Activating Factor);大鼠(Rats);大鼠, 近交BN(Rats, Inbred BN);大鼠, 近交Lew(Rats, Inbred Lew);呼吸道疾病(Respiratory Tract Diseases);组织分布(Tissue Distribution);三唑类(Triazoles);肿瘤坏死因子α(Tumor Necrosis Factor-alpha);呕吐(Vomiting)
DOI
10.1055/s-0031-1296326
PMID
21117500
发布时间
2014-11-20
- 浏览13
Arzneimittel-Forschung
564-70页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



